Top Markets
#1 ADO Protocol ADO Protocol +337.14%
#2 GoPlus Security GoPlus Security +57.08%
#3 Tutorial Tutorial +43.54%
#4 Nockchain Nockchain +38.56%
#5 Starpower Starpower +38.12%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.07%
#7 GAIB AID GAIB AID +24.67%
#8 The Black Bull The Black Bull +23.13%
#9 OpenEden OpenEden +15.63%
#10 Casper Network Casper Network +14.56%
Coin of the day
ADO Protocol ADO Protocol
Cài đặt
Ngôn ngữ
TIếNG VIệT
Tiền tệ
USD
Chủ đề
Traws Pharma, Inc. Traws Pharma, Inc.

Traws Pharma, Inc.

TRAW
Xếp hạng trong cổ phiếu #33205
Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage,... Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage, is dedicated to creating novel small-molecule medications delivered orally to combat both respiratory viral infections and various forms of cancer. Its pipeline includes experimental treatments specifically designed to overcome drug resistance in influenza and COVID-19. These promising candidates include TRX01 (travatrelvir), an Mpro/3CL inhibitor currently undergoing development for COVID-19, and TRX100 (viroxavir), an endonuclease inhibitor advancing through trials for pandemic influenza. Additionally, Traws Pharma's oncology portfolio features narazaciclib, a multi-kinase CDK4/6 inhibitor. This compound is presently in Phase 1/2 clinical trials in cancer patients, being evaluated both independently and in conjunction with letrozole, with the goal of establishing the recommended Phase 2 dosage for future work in endometrial cancer. The company is also investigating oral rigosertib, exploring its potential as a standalone therapy or in combination regimens across diverse cancer types. Originally established in 1998 as Onconova Therapeutics, Inc., the company officially adopted its current name, Traws Pharma, Inc., in April 2024. Its corporate headquarters are located in Newtown, Pennsylvania.
Giá cổ phiếu
$0.54
Vốn hóa thị trường
$8.22M
Thay đổi (1 ngày)
-5.43%
Thay đổi (1 năm)
-64.24%
Quốc gia
US
Giao dịch Traws Pharma, Inc. (TRAW)

Danh mục

Healthcare
Lịch sử giá cổ phiếu của Traws Pharma, Inc. (TRAW)
Giá đóng cửa cao nhất: $0.55 vào 2026-08-01

Giá đóng cửa thấp nhất: $1.18M vào 2013-07-01
Lịch sử giá cổ phiếu của Traws Pharma, Inc. từ 2013 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2026 (TTM) -7.87%
2025 -73.19%
2024 -62.45%
2023 -1.12%
2022 -73.33%
2021 -51.96%
2020 16.11%
2019 -88.57%
2018 -87.09%
2017 -39.73%
2016 -78.39%
2015 -71.56%
2014 -71.82%
2013 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $513.73 30.79%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $993.55 51.96%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.64 7.19%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $255.50 13.38%
BE